|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA-NEW
Nominal 
0.300 -0.035 (-10.448%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 944 | -99.751% | 379,719 | 222,367 | 419,830 | 265,412 |
| Land & other Lease Assets | 0 | -- | 115,998 | 25,998 | 117,998 | 40,003 |
| Intangible Assets | 195 | -99.877% | 158,985 | 160,835 | 162,846 | 1,148,477 |
| Interests in Asso. & JCEs | 312,960 | 12.977% | 277,013 | 277,936 | 16,899 | 16,891 |
| Other Non-current Assets | 2,746 | 382.601% | 569 | 521 | 537 | 18,147 |
| 316,845 | -66.014% | 932,284 | 687,657 | 718,110 | 1,488,930 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 0 | -- | 10,318 | 32,005 | 27,287 | 34,461 | |
| Trade Receivables | 10,052 | -70.142% | 33,666 | 12,452 | 25,964 | 63,580 | |
| Cash & Bank Balances | 1,520 | -74.372% | 5,931 | 9,443 | 7,694 | 28,198 | |
| Other Current Assets | 705 | -97.002% | 23,519 | 33,803 | 419,915 | 183,105 | |
| Assets Held for Sale | 0 | -- | 0 | 180,000 | 96,099 | 0 | |
| 12,277 | -83.282% | 73,434 | 267,703 | 576,959 | 309,344 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 974 | -88.510% | 8,477 | 44,630 | 46,697 | 34,737 | ||
| S-T Debt & Leases | 341,342 | -58.675% | 825,991 | 618,430 | 799,404 | 959,614 | ||
| Other Current Liabilities | 322,771 | -3.715% | 335,225 | 232,913 | 255,669 | 631,166 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 54,666 | 0 | ||
| 665,087 | -43.140% | 1,169,693 | 895,973 | 1,156,436 | 1,625,517 | |||
| Net Current Assets | (652,810) | -40.451% | (1,096,259) | (628,270) | (579,477) | (1,316,173) | ||
| Total Assets Less Current Liabilities | (335,965) | 104.888% | (163,975) | 59,387 | 138,633 | 172,757 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 3,600 | 677.538% | 463 | 213,680 | 52,051 | 67,992 | |||
| Other Non-current Liabilities | 0 | -- | 77,220 | 57,082 | 64,160 | 2,842 | |||
| 3,600 | -95.366% | 77,683 | 270,762 | 116,211 | 70,834 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 1 | 0.000% | 1 | 1 | 1 | 1 | ||||
| Reserves | (339,566) | 40.515% | (241,659) | (211,376) | 16,278 | 105,257 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | (339,565) | 40.515% | (241,658) | (211,375) | 16,279 | 105,258 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 6,143 | (3,335) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| (339,565) | 40.515% | (241,658) | (211,375) | 22,422 | 101,923 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | -- | -- | 20,000 | 20,000 | 380,510 | 179,842 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 22/07/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -143,590,000 |
| %Change | 116.234% |
| EPS / (LPS) | RMB -0.726 |
| NBV Per Share (¥) | RMB -1.286 |